Estimation of anti-SARS-CoV-2 IgG titre among blood donors in Ranchi
Introduction: Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as novel coronavirus (2019-nCoV). The disease presentation ranges from asymptomatic to severe acute respiratory failure requiring intensive care support. Anti-SARS-CoV-2 IgG a...
Main Authors: | Sushma Kumari, Usha Saroj, Ashwini Verma, Abhay Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=10;spage=6385;epage=6389;aulast=Kumari |
Similar Items
-
Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
by: Anita Siller, et al.
Published: (2024-03-01) -
Serial evaluation of antibody titres in patients recovered from COVID-19 and their correlation with disease severity
by: Amrutha S, et al.
Published: (2023-11-01) -
To study heterogeneity in SARS-CoV-2 IgG response titre in patients recovered from COVID-19
by: Avneet Garg, et al.
Published: (2021-09-01) -
Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
by: Myrthe E. Sonneveld, et al.
Published: (2018-01-01) -
Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors
by: Chunhua Luo, et al.
Published: (2021-07-01)